Chemoinformaics analysis of p-Coumaroyl-d-alanine
| Molecular Weight | 235.239 | nRot | 4 |
| Heavy Atom Molecular Weight | 222.135 | nRig | 9 |
| Exact Molecular Weight | 235.084 | nRing | 1 |
| Solubility: LogS | -1.16 | nHRing | 0 |
| Solubility: LogP | 0.776 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 13 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 33.0163 |
| nHD | 3 | BPOL | 15.3477 |
| QED | 0.772 |
| Synth | 2.443 |
| Natural Product Likeliness | 0.207 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.009 |
| HIA | 0.011 |
| CACO-2 | -5.374 |
| MDCK | 0.0000109 |
| BBB | 0.158 |
| PPB | 0.576528 |
| VDSS | 0.254 |
| FU | 0.375198 |
| CYP1A2-inh | 0.069 |
| CYP1A2-sub | 0.077 |
| CYP2c19-inh | 0.082 |
| CYP2c19-sub | 0.054 |
| CYP2c9-inh | 0.034 |
| CYP2c9-sub | 0.594 |
| CYP2d6-inh | 0.06 |
| CYP2d6-sub | 0.25 |
| CYP3a4-inh | 0.037 |
| CYP3a4-sub | 0.116 |
| CL | 2.678 |
| T12 | 0.902 |
| hERG | 0.063 |
| Ames | 0.009 |
| ROA | 0.091 |
| SkinSen | 0.2 |
| Carcinogencity | 0.375 |
| EI | 0.916 |
| Respiratory | 0.038 |
| NR-Aromatase | 0.007 |
| Antiviral | Yes |
| Prediction | 0.590937 |